Varanauskienė E - Search Results

1

Tuberculosis complications after BCG treatment for urinary bladder cancer.

Naudžiūnas A, Juškaitė R, Žiaugrytė I, Unikauskas A, Varanauskienė E, Mašanauskienė E. Naudžiūnas A, et al. Among authors: varanauskiene e. Medicina (Kaunas). 2012;48(11):563-5. Medicina (Kaunas). 2012. PMID: 23455890 Free article.

2

Venomous snakebites.

Adukauskienė D, Varanauskienė E, Adukauskaitė A. Adukauskienė D, et al. Among authors: varanauskiene e. Medicina (Kaunas). 2011;47(8):461-7. Epub 2011 Nov 18. Medicina (Kaunas). 2011. PMID: 22123554 Free article.

3

[An update on multiple insulin injection therapy in type 1 and 2 diabetes].

Varanauskiene E, Varanauskaite I, Ceponis J. Varanauskiene E, et al. Medicina (Kaunas). 2006;42(9):770-9. Medicina (Kaunas). 2006. PMID: 17028476 Free article. Review. Lithuanian.

4

Can blood glucose self-monitoring improve treatment outcomes in type 2 diabetes?

Varanauskiene E. Varanauskiene E. Diabetes Res Clin Pract. 2008 Dec 15;82 Suppl 2:S112-7. doi: 10.1016/j.diabres.2008.09.025. Epub 2008 Oct 29. Diabetes Res Clin Pract. 2008. PMID: 18963203 Review.

5

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.

6

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.

7

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study.

Pfister R, Cairns R, Erdmann E, Schneider CA; PROactive investigators. Pfister R, et al. Diabet Med. 2011 Oct;28(10):1206-12. doi: 10.1111/j.1464-5491.2011.03281.x. Diabet Med. 2011. PMID: 21388447 Free article.

8

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team. Home PD, et al. Lancet. 2009 Jun 20;373(9681):2125-35. doi: 10.1016/S0140-6736(09)60953-3. Epub 2009 Jun 6. Lancet. 2009. PMID: 19501900 Clinical Trial.

9

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).

Erdmann E, Charbonnel B, Wilcox RG, Skene AM, Massi-Benedetti M, Yates J, Tan M, Spanheimer R, Standl E, Dormandy JA; PROactive Investigators. Erdmann E, et al. Diabetes Care. 2007 Nov;30(11):2773-8. doi: 10.2337/dc07-0717. Epub 2007 Jul 31. Diabetes Care. 2007. PMID: 17666462 Clinical Trial.

10

Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes.

Hanefeld M, Herman GA, Wu M, Mickel C, Sanchez M, Stein PP; Sitagliptin Study 014 Investigators. Hanefeld M, et al. Curr Med Res Opin. 2007 Jun;23(6):1329-39. doi: 10.1185/030079907X188152. Epub 2007 Apr 30. Curr Med Res Opin. 2007. PMID: 17559733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page